Genetic Engineering and Gene Therapy

The Genetic Engineering and Gene Therapy Core (GEGT) provides access to an expanded array of customized viral and non-viral vectors, cell marking and reprogramming services, and state-of-the-art reagents for site-specific gene insertion. The mission of the GEGT Core is to work cooperatively with investigators to facilitate the development of genetic engineering reagents required for their in vitroand in vivoexperiments.

  • Custom made and previously generated :
  • Recombinant (replication-deficient) adenoviral vectors
  • Recombinant lentiviral vectors

Location and Contacts

Genetic Engineering and Gene Therapy Ullmann 525
  • Jayanta Roy-Chowdhury, MBBS, MRCP
    Scientific Director

  • Xia Wang, M.D, Ph.D.
    Operations Director